| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-87 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56933
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-24 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-01 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 |
| filingDate |
1989-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_707c0f46c69e420a4e5ece01d25f1836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb888f0f282175330c8348fab15c75a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e290490fb0257998b16cf4934325adff |
| publicationDate |
1991-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0445229-A1 |
| titleOfInvention |
Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide |
| abstract |
The present invention relates to a carbohydrate receptor for mycoplasma pneumoniae and mycoplasma hominus and to its use for detecting the presence of mycoplasmas in biological fluids and in diseased tissues and cells. The receptor can be contained in a composition comprising a pharmaceutically acceptable excipient. Methods are provided for purifying, detecting or extracting mycoplasmas contained in diseased tissue or fluids. The receptor contains sulfatures, dextran sulfate, sialyloligo-saccharides and mixtures of these compounds. |
| priorityDate |
1988-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |